Literature DB >> 9539251

Model for the molecular genetic diagnosis of endometrial cancer using K-ras mutation analysis.

R M Al-Jehani1, A R Jeyarajah, B Hagen, E V Hogdall, D H Oram, I J Jacobs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9539251     DOI： 10.1093/jnci/90.7.540

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  3 in total

1.  Biological significance of prolactin in gynecologic cancers.

Authors:  Vera V Levina; Brian Nolen; YunYun Su; Andrew K Godwin; David Fishman; Jinsong Liu; Gil Mor; Larry G Maxwell; Ronald B Herberman; Miroslaw J Szczepanski; Marta E Szajnik; Elieser Gorelik; Anna E Lokshin
Journal:  Cancer Res       Date:  2009-06-02       Impact factor: 12.701

2.  K-ras mutation in the endometrium of tamoxifen-treated breast cancer patients, with a comparison of tamoxifen and toremifene.

Authors:  T Hachisuga; H Tsujioka; S Horiuchi; T Udou; M Emoto; T Kawarabayashi
Journal:  Br J Cancer       Date:  2005-03-28       Impact factor: 7.640

3.  CIB1 contributes to oncogenic signalling by Ras via modulating the subcellular localisation of sphingosine kinase 1.

Authors:  W Zhu; B L Gliddon; K E Jarman; P A B Moretti; T Tin; L V Parise; J M Woodcock; J A Powell; A Ruszkiewicz; M R Pitman; S M Pitson
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.